Skip to content

THERALINK TECHNOLOGIES, INC.: 10-Q filed 2012-10-15

What THERALINK TECHNOLOGIES, INC. reported in its quarterly report filed 2012-10-15 (fiscal Q2 2012): 25 published measures, 97 facts as tagged in accession 0001062993-12-004097.

This filing

Form
10-Q (quarterly report)
Filed
2012-10-15
Fiscal period
fiscal Q2 2012
Accession
0001062993-12-004097 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All THERALINK TECHNOLOGIES, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2012-08-311,845,365USD
At 2012-02-281,128,325USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2012-08-31889,190USD
At 2012-02-28882,960USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2012-08-31956,175USD
At 2012-02-28245,365USD
At 2011-02-28983,996USD
At 2010-02-28-50,517USD
At 2009-02-28-6,715USD
At 2008-02-28-56,108USD
At 2007-02-28-5,097USD
At 2006-02-28-15,637USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2012-08-3165,172USD
At 2012-02-29258,140USD
At 2012-02-28258,140USD
At 2011-08-31198,445USD
At 2011-02-28549,392USD
At 2005-03-180USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2012-06-01 to 2012-08-31903,629USD92
2012-03-01 to 2012-08-31578,672USD184
2005-03-19 to 2012-08-31-1,672,654USD2723
2011-03-01 to 2012-02-28-952,543USD365
2011-06-01 to 2011-08-31-316,952USD92
2011-03-01 to 2011-08-31-768,164USD184
2010-03-01 to 2011-02-28-1,049,087USD365
2009-03-01 to 2010-02-28-58,201USD365
2008-02-29 to 2009-02-28-53,957USD366
2007-03-01 to 2008-02-28-65,411USD365
2006-03-01 to 2007-02-28-50,890USD365
2005-03-19 to 2006-02-28-21,237USD347

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2012-03-01 to 2012-08-31-192,968USD184
2005-03-19 to 2012-08-31-1,674,728USD2723
2011-03-01 to 2011-08-31-600,947USD184

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2012-03-01 to 2012-08-310USD184
2005-03-19 to 2012-08-312,685,000USD2723
2011-03-01 to 2011-08-31250,000USD184

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2012-03-01 to 2012-08-310USD184
2005-03-19 to 2012-08-31-945,100USD2723
2011-03-01 to 2011-08-310USD184

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2012-06-01 to 2012-08-3120,836,000shares92
2012-03-01 to 2012-08-3120,836,000shares184
2011-06-01 to 2011-08-3120,836,000shares92
2011-03-01 to 2011-08-3120,836,000shares184

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2012-06-01 to 2012-08-310.043USD/shares92
2012-03-01 to 2012-08-310.028USD/shares184
2011-06-01 to 2011-08-31-0.015USD/shares92
2011-03-01 to 2011-08-31-0.037USD/shares184

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2012-06-01 to 2012-08-310USD92
2012-03-01 to 2012-08-31132,138USD184
2005-03-19 to 2012-08-31346,050USD2723
2011-03-01 to 2012-02-28213,912USD365
2011-06-01 to 2011-08-3158,142USD92
2011-03-01 to 2011-08-31115,492USD184

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2012-08-311,145,474USD
At 2012-02-28384,293USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2012-06-01 to 2012-08-319,924USD92
2012-03-01 to 2012-08-3116,122USD184
2005-03-19 to 2012-08-3157,097USD2723
2011-06-01 to 2011-08-312,978USD92
2011-03-01 to 2011-08-3112,374USD184

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2012-08-3165,708USD
At 2012-02-28106,635USD

Common-stock repurchase payments

Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.

PeriodValueUnitDays
2012-03-01 to 2012-08-310USD184
2005-03-19 to 2012-08-315,000USD2723
2011-03-01 to 2011-08-310USD184

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2012-06-01 to 2012-08-31141,496USD92
2012-03-01 to 2012-08-31506,844USD184
2005-03-19 to 2012-08-313,565,927USD2723
2011-06-01 to 2011-08-31405,647USD92
2011-03-01 to 2011-08-31943,147USD184

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2012-08-310USD
At 2012-02-282,169USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2012-06-01 to 2012-08-3145,125USD92
2012-03-01 to 2012-08-3185,516USD184
2005-03-19 to 2012-08-31828,373USD2723
2011-06-01 to 2011-08-3188,695USD92
2011-03-01 to 2011-08-31174,983USD184

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2012-08-3120,836,000shares
At 2012-02-2820,836,000shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2012-08-312,626,745USD
At 2012-02-282,494,607USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

PeriodValueUnitDays
At 2012-08-310USD
At 2012-02-290USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2012-06-01 to 2012-08-318,562USD92
2012-03-01 to 2012-08-3118,607USD184
2005-03-19 to 2012-08-31252,098USD2723
2011-06-01 to 2011-08-3116,294USD92
2011-03-01 to 2011-08-3139,440USD184

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2012-03-01 to 2012-08-310USD184
2005-03-19 to 2012-08-311,985,000USD2723
2011-03-01 to 2011-08-310USD184

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2012-03-01 to 2012-08-31-40,927USD184
2005-03-19 to 2012-08-3165,708USD2723
2011-03-01 to 2011-08-31-24,455USD184

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2012-03-01 to 2012-08-31-2,169USD184
2005-03-19 to 2012-08-31-26,680USD2723
2011-03-01 to 2011-08-31-7,259USD184

Inspect the source

Entity
THERALINK TECHNOLOGIES, INC. / CIK 0001362703
Captured
SEC response SHA-256
8ea68b29937a9dc79f3f437bfa115ba2d25bc4aa61d4ac37350bf0c10a93ef12

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001362703.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))